Form D · Biotechnology
ILIAD BIOTECHNOLOGIES, LLC
Weston, FL · CIK 0001658367
Offering snapshot reported Oct 25, 2022 · SEC filing
- Reported sold
- $3.04M Offering amount: $3.04M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 25, 2022 | Initial | $3,036,142 | No comparison | 43 | SEC filing |
| Sep 6, 2022 | Initial | $42,835,745 | No comparison | 42 | SEC filing |
| Mar 3, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 31, 2020 | Amendment | $4,300,000 | $4,300,000vs Nov 20, 2019 | 36 | SEC filing |
| Nov 20, 2019 | Initial | $0 | No comparison | 0 | SEC filing |
| Mar 21, 2019 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Dec 18, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 17, 2018 | Initial | $550,000 | No comparison | 2 | SEC filing |
| Feb 8, 2018 | Initial | $675,220 | No comparison | 11 | SEC filing |
| Apr 13, 2017 | Initial | $1,250,000 | No comparison | 1 | SEC filing |
| Aug 23, 2016 | Initial | $955,000 | No comparison | 18 | SEC filing |
| Aug 12, 2016 | Initial | $545,805 | No comparison | 8 | SEC filing |
| Nov 18, 2015 | Amendment | $640,000 | $0vs Nov 13, 2015 | 8 | SEC filing |
| Nov 13, 2015 | Initial | $640,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $28.3K
- Finders' fees
- $0
- Form D file number
- 021-462777
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Walter C. Greenblatt | 4723413 | Walter C. Greenblatt & Associates · CRD 129291 |
Source: Form D, filed Oct 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cuong Do | Director |
| Eric Edidin | Director |
| Corey Horowitz | Director |
| David Johnston | Executive |
| Avi Naider | Director |
| Ariel Pablos Mendez | Director |
| Keith Rubin | Director, Executive |
| Ventures, Llc Seedlings Life Science | Director |
| Ken Solovay | Executive |
| Bin Yan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4581 Weston Road Suite 260
Weston, FL, 33331
Weston, FL, 33331